InsidersTradesSigma
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by KUMAR AMIT, Chairman & CEO. Officer active across 1 companies, notably Anixa Biosciences Inc. In total, 8 filings have been published. Total volume traded: €226k. The latest transaction was filed on 7 January 2022 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
€53,11220,000 shares@ €2.65560.056% mcap47.1% of flow
Common Stock
SEC:0001493152-22-000640·
Ideal exit: 4 Oct 2022 (T+270)
€53,11220,000 shares@ €2.65560.056% mcap23.5% of flow
Common Stock
SEC:0001493152-22-000640:0·
Ideal exit: 4 Oct 2022 (T+270)
€8,1652,000 shares@ €4.08260.0086% mcap7.2% of flow
Common Stock
SEC:0001493152-21-026828·
Ideal exit: 26 Jul 2022 (T+270)
€8,1652,000 shares@ €4.08260.0086% mcap3.6% of flow
Common Stock
SEC:0001493152-21-026828:0·
Ideal exit: 26 Jul 2022 (T+270)
€18,1785,000 shares@ €3.63550.019% mcap16.1% of flow
Common Stock
SEC:0001493152-21-017833·
Ideal exit: 19 Apr 2022 (T+270)
€18,1785,000 shares@ €3.63550.019% mcap8.1% of flow
Common Stock
SEC:0001493152-21-017833:0·
Ideal exit: 19 Apr 2022 (T+270)
€33,35610,000 shares@ €3.33560.035% mcap29.6% of flow
Common Stock
SEC:0001493152-21-017276·
Ideal exit: 12 Apr 2022 (T+270)
€33,35610,000 shares@ €3.33560.035% mcap14.8% of flow
Common Stock
SEC:0001493152-21-017276:0·
Ideal exit: 12 Apr 2022 (T+270)
8 of 8 declarations
About KUMAR AMIT
Amit Kumar is the Chief Executive Officer of Anixa Biosciences Inc. In this role, he is responsible for the strategic direction of the company and innovation in the biotechnology field. Under his leadership, Anixa Biosciences strives to develop innovative solutions to meet market needs. Amit Kumar works closely with his team to achieve the company's growth objectives.
